EUVIMEDEUVIMED entdecken
Crossref

Determining the optimal initial dose for Japanese patients with nocturnal polyuria using an initial dose of desmopressin 50 μg

Hirofumi Kurose iD, Keisuke Komiya iD, Naoyuki Ogasawara iD, Kosuke Ueda iD, Katsuaki Chikui iD, Kiyoaki Nishihara iD, Makoto Nakiri iD, Mitsunori Matsuo, Shigetaka Suekane iD, Tsukasa Igawa iD

LUTS: Lower Urinary Tract Symptoms · 2023

DOI: 10.1111/luts.12474 ↗

Kurz gefasst

Fachartikel in der Zeitschrift LUTS: Lower Urinary Tract Symptoms, 2023. Verfasst von Hirofumi Kurose und 9 weiteren Autor:innen. Beteiligte Einrichtung: Department of Urology, Chikugo City Hospital, Chikugo, Japan. Hauptthemen laut MEDLINE: Nocturia, Hyponatremia. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 16 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Objective

There is no consistent opinion on the optimal initial dose of desmopressin for patients with nocturnal polyuria. Over a period of 12 weeks, we investigated the safety and efficacy of an initial dose of 50 μg of desmopressin for elderly men.

Methods

Eighty patients (mean age: 78.8 years) were started on an initial dose of 50 μg of desmopressin for nocturia associated with nocturnal polyuria. Safety and efficacy were evaluated after 1, 4, and 12 weeks using a frequency‐volume chart, Athens Insomnia Scale, Patient Global Impression of Improvement scale, physical examination, blood tests, and a body composition analyzer.

Results

Along with reduction in the frequency and volume of night‐time urination, improvements in hours of undisturbed sleep, nocturnal polyuria index, and International Prostate Symptom Score, and Overactive Bladder Symptom Scores on quality of life measures were also observed. Hyponatremia was observed in 15 patients (18.7%). However, only 5.0% of patients had hyponatremia after the dose was reduced to 25 μg, and the continuation rate at 12 weeks was high at 87.5%. Age and other physical factors, such as body mass index, body water content, body fat mass, and muscle mass were not significant predictors of adverse events.

Conclusions

Our study suggests that an initial dose of 50 μg is more effective than a uniformly minimum dose based on factors such as age and physique. Furthermore, a high continuation rate can be achieved by appropriately reducing the dose, if adverse events occur.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

NocturiaHyponatremiaMaleHumansAgedDeamino Arginine VasopressinPolyuriaAntidiuretic AgentsQuality of LifeEast Asian People

Stichwörter der Autor:innen

desmopressinhyponatremianocturnal polyuriaoptimal initial dosesafety

Substanzen

Deamino Arginine VasopressinAntidiuretic Agents

Autor:innen und Institutionen

  • Department of Urology, Chikugo City Hospital, Chikugo, Japan.
  • Department of Urology, Kurume University School of Medicine, Kurume, Japan.

ORCID-Profile: Hirofumi Kurose, Keisuke Komiya, Naoyuki Ogasawara, Kosuke Ueda, Katsuaki Chikui, Kiyoaki Nishihara, Makoto Nakiri, Shigetaka Suekane, Tsukasa Igawa

Zitieren

APA

Kurose, H., Komiya, K., Ogasawara, N., Ueda, K., Chikui, K., Nishihara, K., Nakiri, M., Matsuo, M., Suekane, S., & Igawa, T. (2023). Determining the optimal initial dose for Japanese patients with nocturnal polyuria using an initial dose of desmopressin 50 μg. LUTS: Lower Urinary Tract Symptoms. https://doi.org/10.1111/luts.12474

Vancouver

Kurose H, Komiya K, Ogasawara N, Ueda K, Chikui K, Nishihara K, et al. Determining the optimal initial dose for Japanese patients with nocturnal polyuria using an initial dose of desmopressin 50 μg. LUTS: Lower Urinary Tract Symptoms. 2023. doi:10.1111/luts.12474

BibTeX
@article{Kurose2023,
  author = {Kurose, Hirofumi and Komiya, Keisuke and Ogasawara, Naoyuki and Ueda, Kosuke and Chikui, Katsuaki and Nishihara, Kiyoaki and Nakiri, Makoto and Matsuo, Mitsunori and Suekane, Shigetaka and Igawa, Tsukasa},
  title = {Determining the optimal initial dose for Japanese patients with nocturnal polyuria using an initial dose of desmopressin 50 μg},
  journal = {LUTS: Lower Urinary Tract Symptoms},
  year = {2023},
  doi = {10.1111/luts.12474}
}
Kostenlos starten →